Coral Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve 1. To consider and adopt ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Coral Laboratories has informed BSE that its Board of Directors will meet on August 13, 2025. Key agenda items include: (1) adopting the unaudited standalone financial results for Q1 FY26 (quarter ended June 30, 2025), (2) approving the notice and fixing the date for the 43rd Annual General Meeting, (3) recommending appointment of new Statutory Auditors as the existing auditor M/s M. A. Parekh & Associates completes their term, and (4) considering alteration of the Object clause of the Memorandum of Association. No financial numbers or detailed business rationale have been disclosed in this advance notice.
This is a routine pre-results intimation — investors should watch for the Q1 FY26 results release after August 13. The proposed alteration to the Object clause could signal a potential diversification or new business direction, while the auditor rotation is a standard procedural step.